<i>Sutherlandia frutescens</i> (Fabaceae) extracts used for treating tuberculosis do not have high activity against <i>Mycobacterium smegmatis</i>
Sutherlandia frutescens (L) R. Br. contains several essential, bioactive compounds with clinically proven pharmacological activities. Sutherlandia is prescribed for people with tuberculosis but it is still not known what compounds in this plant act against Mycobacterium tuberculosis and its mode of...
Main Authors: | Itumeleng H. Mabusa, Rachmond Howard, Peter Masoko |
---|---|
Format: | Article |
Language: | Afrikaans |
Published: |
South African Journal of Science and Technology
2017-12-01
|
Series: | South African Journal of Science and Technology |
Subjects: | |
Online Access: | https://journals.satnt.aosis.co.za/index.php/satnt/article/view/1486 |
Similar Items
-
Die toets van ekstrakte uit Sutherlandia frutescens (Fabaceae) op Mycobaterium smegmatis in die behandeling van tering
by: Itumeleng H. Mabusa, et al.
Published: (2017-12-01) -
Biosynthesis of phospholipid in Mycobacterium smegmatis.
by: Lee, Young Soon
Published: (1971) -
Comparison of the physicochemical characteristics and flavonoid release profiles of Sutherlandia frutescens phytosomes versus liposomes
by: Daghman, Mohamed Ibrahim
Published: (2016) -
Anticancer Potential of <i>Sutherlandia frutescens</i> and <i>Xysmalobium undulatum</i> in LS180 Colorectal Cancer Mini-Tumors
by: Chrisna Gouws, et al.
Published: (2021-01-01) -
Characterization of resuscitation promoting factors in Mycobacterium smegmatis
by: Mapela, Lusanda Thato
Published: (2012)